Spots Global Cancer Trial Database for vinorelbine tartrate
Every month we try and update this database with for vinorelbine tartrate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma | NCT01222715 | Adult Rhabdomyo... Childhood Alveo... Childhood Pleom... Childhood Rhabd... Previously Trea... Recurrent Adult... Recurrent Child... | Bevacizumab Cyclophosphamid... Laboratory Biom... Temsirolimus Vinorelbine Tar... | - 29 Years | National Cancer Institute (NCI) | |
| Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003240 | Lung Cancer | cisplatin ifosfamide mitomycin C vinblastine sul... vindesine vinorelbine tar... conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer | NCT00002813 | Cervical Cancer | cisplatin vinorelbine tar... | - | GOG Foundation | |
| Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer | NCT00003584 | Kidney Cancer | estramustine ph... prednisone vinorelbine tar... | - 120 Years | University of New Mexico | |
| Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases | NCT00026494 | Metastatic Canc... | temozolomide vinorelbine tar... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00005838 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | shark cartilage... placebo cisplatin vinorelbine tar... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00736814 | Lung Cancer | carboplatin docetaxel gemcitabine hyd... vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00736814 | Lung Cancer | carboplatin docetaxel gemcitabine hyd... vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement | NCT00003902 | Breast Cancer | capecitabine vinorelbine tar... | 65 Years - | Swiss Group for Clinical Cancer Research | |
| Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer | NCT00004237 | Breast Cancer | cyclophosphamid... doxorubicin hyd... epirubicin hydr... mitoxantrone hy... vinorelbine tar... conventional su... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00026156 | Lung Cancer | docetaxel vinorelbine tar... | 18 Years - | SWOG Cancer Research Network | |
| Vinorelbine in Treating Patients With Metastatic Prostate Cancer | NCT00003259 | Prostate Cancer | vinorelbine tar... | 18 Years - 85 Years | Swiss Group for Clinical Cancer Research | |
| Vinorelbine in Advanced BRAF-like Colon Cancer | NCT03482362 | Colon Cancer | Vinorelbine Tar... | 18 Years - | The Netherlands Cancer Institute | |
| A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. | NCT00432562 | Breast Cancer Non-small Cell ... Non-Hodgkins Ly... | Vinorelbine Tar... | 18 Years - | Mast Therapeutics, Inc. | |
| Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00004100 | Lung Cancer | cisplatin gemcitabine hyd... vinorelbine tar... | - 69 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00005825 | Lung Cancer | cisplatin mitomycin C tretinoin vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer | NCT00083083 | Lung Cancer | carboplatin cisplatin docetaxel etoposide paclitaxel vinblastine sul... vinorelbine tar... gene expression... positron emissi... fludeoxyglucose... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | NCT00093808 | Breast Cancer | trastuzumab capecitabine vinorelbine tar... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain | NCT00476827 | Breast Cancer | Bevacizumab Docetaxel CPT-11 Paclitaxel Vinorelbine Tar... Gemcitabine | 18 Years - | Duke University | |
| Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma | NCT01026220 | Childhood Nodul... Stage III Child... Stage IV Childh... | bleomycin sulfa... doxorubicin hyd... liposomal vincr... vinorelbine tar... cyclophosphamid... etoposide phosp... prednisone filgrastim ifosfamide | - 21 Years | Children's Oncology Group | |
| Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | NCT00003622 | Prostate Cancer | paclitaxel vinorelbine tar... | 18 Years - 120 Years | George Washington University | |
| Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00309998 | Lung Cancer | bevacizumab vinorelbine tar... | 70 Years - | University of Rochester | |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00005838 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | shark cartilage... placebo cisplatin vinorelbine tar... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) | NCT01443078 | Lung Cancer | pemetrexed cisplatin Carboplatin Gemcitabine Hyd... Vinorelbine Tar... Docetaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vinorelbine in Treating Patients With Metastatic Prostate Cancer | NCT00003259 | Prostate Cancer | vinorelbine tar... | 18 Years - 85 Years | Swiss Group for Clinical Cancer Research | |
| Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00003447 | Lung Cancer | gemcitabine hyd... vinorelbine tar... | 70 Years - | National Cancer Institute (NCI) | |
| SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | NCT00337194 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular S... Recurrent Adult... | monoclonal anti... placebo vinorelbine tar... pegylated lipos... gemcitabine hyd... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00054197 | Lung Cancer | gemcitabine hyd... paclitaxel poli... vinorelbine tar... | 18 Years - 120 Years | CTI BioPharma | |
| Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | NCT00002823 | Lung Cancer | cisplatin etoposide vinblastine sul... vindesine vinorelbine tar... radiation thera... | 18 Years - 75 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | NCT00379457 | Sarcoma | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide topotecan hydro... vincristine sul... vinorelbine tar... conventional su... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | NCT00003622 | Prostate Cancer | paclitaxel vinorelbine tar... | 18 Years - 120 Years | George Washington University | |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer | NCT00287963 | Lung Cancer | topotecan hydro... vinorelbine tar... | 18 Years - 120 Years | Medical University of South Carolina | |
| Vinorelbine in Treating Older Women With Stage IV Breast Cancer | NCT00022152 | Breast Cancer | vinorelbine tar... | 65 Years - | Alliance for Clinical Trials in Oncology | |
| Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00006215 | Lung Cancer | filgrastim docetaxel vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma | NCT01026220 | Childhood Nodul... Stage III Child... Stage IV Childh... | bleomycin sulfa... doxorubicin hyd... liposomal vincr... vinorelbine tar... cyclophosphamid... etoposide phosp... prednisone filgrastim ifosfamide | - 21 Years | Children's Oncology Group | |
| Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer | NCT00003159 | Lung Cancer | carboplatin cisplatin docetaxel gemcitabine hyd... ifosfamide mitomycin C paclitaxel vinblastine sul... vinorelbine tar... conventional su... neoadjuvant the... | - | National Cancer Institute (NCI) | |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | NCT00002949 | Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer | paclitaxel vinorelbine tar... radiation thera... | 18 Years - | University of Chicago | |
| Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00075699 | Malignant Mesot... | cisplatin mitomycin C vincristine sul... vinorelbine tar... pain therapy psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | NCT00049660 | Breast Cancer | capecitabine vinorelbine tar... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer | NCT00017394 | Male Breast Can... Recurrent Breas... Stage IV Breast... | bevacizumab vinorelbine tar... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix | NCT00064077 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVB Cervi... | Cisplatin Gemcitabine Hyd... Paclitaxel Quality-of-Life... Topotecan Hydro... Vinorelbine Tar... | 18 Years - | GOG Foundation | |
| Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00079287 | Lung Cancer | carboplatin docetaxel gemcitabine hyd... paclitaxel vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer | NCT00194792 | Estrogen Recept... HER2-negative B... Progesterone Re... Stage I Breast ... Stage II Breast... Stage IIIA Brea... | exemestane triptorelin pam... capecitabine methotrexate vinorelbine tar... paclitaxel therapeutic con... radiation thera... laboratory biom... | 18 Years - | University of Washington | |
| the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment | NCT03358004 | Triple Negative... | Vinorelbine Tar... Capecitabine 50... | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer | NCT00287963 | Lung Cancer | topotecan hydro... vinorelbine tar... | 18 Years - 120 Years | Medical University of South Carolina | |
| Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies | NCT00641160 | Nonhematologic ... | vinorelbine tar... vinorelbine tar... vinorelbine tar... | 18 Years - | Metronome Therapeutics | |
| DP303c in Patients With HER2-positive Advanced Breast Cancer | NCT05901935 | HER2-positive A... | DP303c Trastuzumab Vinorelbine Tar... Capecitabine ta... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003240 | Lung Cancer | cisplatin ifosfamide mitomycin C vinblastine sul... vindesine vinorelbine tar... conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | NCT00002949 | Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer | paclitaxel vinorelbine tar... radiation thera... | 18 Years - | University of Chicago | |
| Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00017459 | Lung Cancer | cisplatin tirapazamine vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | NCT00253591 | Lung Cancer | cisplatin vinorelbine tar... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer | NCT00003400 | Prostate Cancer | filgrastim carmustine cisplatin melphalan vinorelbine tar... peripheral bloo... | 18 Years - 70 Years | University of Maryland, Baltimore | |
| the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment | NCT03358004 | Triple Negative... | Vinorelbine Tar... Capecitabine 50... | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer | NCT00602797 | Recurrent Non-S... Stage IV Non-Sm... | Paclitaxel Quality-of-Life... Questionnaire A... Vinorelbine Tar... | 70 Years - | University of Nebraska | |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery | NCT00324805 | Stage IB Lung N... Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... | Bevacizumab Cisplatin Docetaxel Gemcitabine Hyd... Laboratory Biom... Pemetrexed Diso... Questionnaire A... Vinorelbine Tar... | 18 Years - | National Cancer Institute (NCI) | |
| Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer | NCT00194792 | Estrogen Recept... HER2-negative B... Progesterone Re... Stage I Breast ... Stage II Breast... Stage IIIA Brea... | exemestane triptorelin pam... capecitabine methotrexate vinorelbine tar... paclitaxel therapeutic con... radiation thera... laboratory biom... | 18 Years - | University of Washington | |
| Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00627354 | Prostate Cancer | etoposide mitoxantrone hy... prednisone vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer | NCT00003730 | Breast Cancer | fluorouracil vinorelbine tar... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors | NCT00006088 | Unspecified Adu... | vinorelbine tar... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer | NCT00002813 | Cervical Cancer | cisplatin vinorelbine tar... | - | GOG Foundation | |
| Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | NCT00093808 | Breast Cancer | trastuzumab capecitabine vinorelbine tar... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer | NCT00863512 | Lung Cancer | cisplatin docetaxel gemcitabine hyd... pemetrexed diso... vinorelbine tar... standard follow... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma | NCT00030459 | Malignant Mesot... | cisplatin mitomycin C vinblastine sul... vinorelbine tar... | - | National Cancer Institute (NCI) | |
| the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment | NCT03358004 | Triple Negative... | Vinorelbine Tar... Capecitabine 50... | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00005865 | Lung Cancer | vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | NCT00920153 | Lymphoma | bleomycin sulfa... ABVD regimen carmustine cisplatin cytarabine dacarbazine dexamethasone doxorubicin hyd... etoposide gemcitabine hyd... ifosfamide melphalan methylprednisol... mitoguazone vincristine sul... vindesine vinorelbine tar... allogeneic hema... autologous hema... | 18 Years - 65 Years | French Innovative Leukemia Organisation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
